Mission: To develop preclinical research technologies exclusively using adult stem cells and ips cells that will advance drug discovery and regenerative medicine. And to educate scientists and the next generation of scientists in pro-life bioethics.
Programs: To develop a collaborative basic and clinical research program in our four core research areas: cancer, neurodegenerative diseases, rare diseases, and adult stem cell therapies.